Yun Kim

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 18

Top Topics

Amyotrophic Lateral Sclerosis

Top Venues

Life (Basel, Switzerland)

Drug design, development and therapy

British journal of clinical pharmacology

Journal of personalized medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Yun Kim, Sungha Moon, Su Jin Rhee
Optimal Once-Daily Busulfan Administration in Pediatric Patients: A Simulation-Based Investigation of Intravenous Infusion Times. Drug design, development and therapy 18 (2024)
Jae Hyeon Yu, Sang Won Lee, Yoon Jung Kim, Won Young Kim, Min Jung Lee, Yun Kim
Assessing Post-Marketing Requirements for Orphan Drugs: A Cross-Sectional Analysis of FDA and EMA Oversight. Clinical pharmacology and therapeutics (2024)
Yun Kim, Sungha Moon, Su Jin Rhee
Optimal Once-Daily Busulfan Administration in Pediatric Patients: A Simulation-Based Investigation of Intravenous Infusion Times. Drug design, development and therapy 18 (2024)
Yoon Jin Roh, Yun Kim, Jae Sun Lee, Ju Hee Oh, Seung Min Lee, Eileen Laurel Yoon, Sung Ryol Lee, Dae Won Jun
Regulation of Hepatocyte Nuclear Factor 4α Attenuated Lipotoxicity but Increased Bile Acid Toxicity in Non-Alcoholic Fatty Liver Disease. Life (Basel, Switzerland) 12 (11) (2022)
Sae Im Jeong, Yun Kim, Jae Jin Nah, Wan Huh, In-Jin Jang, Jun Gi Hwang, Seung Hwan Lee
Pharmacokinetic and pharmacodynamic interaction of DWP16001, a sodium-glucose cotransporter 2 inhibitor, with gemigliptin and metformin in healthy adults. British journal of clinical pharmacology (2022)
Sae Im Jeong, Yun Kim, Jae Jin Nah, Wan Huh, In-Jin Jang, Jun Gi Hwang, Seung Hwan Lee
Pharmacokinetic and Pharmacodynamic Interaction of DWP16001, an SGLT2 Inhibitor, with Gemigliptin and Metformin in Healthy Adults. British journal of clinical pharmacology (2022)
Eun Jeoung Lee, Yun Kim, Ji Eun Kim, Eileen Laurel Yoon, Sung Ryol Lee, Dae Won Jun
ALS-L1023 from Melissa officinalis Alleviates Liver Fibrosis in a Non-Alcoholic Fatty Liver Disease Model. Life (Basel, Switzerland) 13 (1) (2022)
Eun Jeoung Lee, Yun Kim, Ji Eun Kim, Eileen Laurel Yoon, Sung Ryol Lee, Dae Won Jun
ALS-L1023 from Melissa officinalis Alleviates Liver Fibrosis in a Non-Alcoholic Fatty Liver Disease Model. Life (Basel, Switzerland) 13 (1) (2022)
Eun Jeoung Lee, Yun Kim, Ji Eun Kim, Eileen Laurel Yoon, Sung Ryol Lee, Dae Won Jun
ALS-L1023 from Melissa officinalis Alleviates Liver Fibrosis in a Non-Alcoholic Fatty Liver Disease Model. Life (Basel, Switzerland) 13 (1) (2022)
Yun Kim, Soohyun Kim, Jinsook Park, Howard Lee
Clinical Response and Hospital Costs of Therapeutic Drug Monitoring for Vancomycin in Elderly Patients. Journal of personalized medicine 12 (2) (2022)
Eun Jeoung Lee, Yun Kim, Ji Eun Kim, Eileen Laurel Yoon, Sung Ryol Lee, Dae Won Jun
ALS-L1023 from Melissa officinalis Alleviates Liver Fibrosis in a Non-Alcoholic Fatty Liver Disease Model. Life (Basel, Switzerland) 13 (1) (2022)
Hark Kyun Kim, Jeong Won Kang, Young-Whan Park, Jung Young Kim, Minchae Kim, Soo Jin Kim, Se-Mi Kim, Keun Ho Ryu, Seonghae Yoon, Yun Kim, Joo-Youn Cho, Keun Seok Lee, Tak Yun, Kiwon Kim, Mi Hyang Kwak, Tae-Sung Kim, Jinsoo Chung, Joong-Won Park
Phase I and pharmacokinetic study of the vascular-disrupting agent CKD-516 (NOV120401) in patients with refractory solid tumors. Pharmacology research & perspectives 8 (2) (2021)
Yun Kim
Emerging Treatment Options for Sarcopenia in Chronic Liver Disease. Life (Basel, Switzerland) 11 (3) (2021)
Yun Kim, Sangwon Lee, Yohan Kim, In-Jin Jang, Seung Hwan Lee
Pharmacokinetics and safety of a novel influenza treatment (baloxavir marboxil) in Korean subjects compared with Japanese subjects. Clinical and translational science (2021)
Hyounggyoon Yoo, Yun Kim, In-Jin Jang, Kyung-Sang Yu, Seung Hwan Lee
Pharmacokinetic/Pharmacodynamic Interactions Between Evogliptin and Glimepiride in Healthy Male Subjects. Drug design, development and therapy 14 (2020)
Yun Kim, Oliver Hatley, Su-Jin Rhee, Sojeong Yi, Hyun A Lee, Sumin Yoon, Jae-Yong Chung, Kyung-Sang Yu, Howard Lee
Development of a Korean-specific virtual population for physiologically based pharmacokinetic modelling and simulation. Biopharmaceutics & drug disposition 40 (3-4) (2019)
Yun Kim, Seonghae Yoon, Yewon Choi, Seo Hyun Yoon, Joo-Youn Cho, In-Jin Jang, Kyung-Sang Yu, Jae-Young Chung
Influence of OATP1B1 and BCRP polymorphisms on the pharmacokinetics and pharmacodynamics of rosuvastatin in elderly and young Korean subjects. Scientific reports 9 (1) (2019)
Sumin Yoon, Sojeong Yi, Su Jin Rhee, Hyun A Lee, Yun Kim, Kyung-Sang Yu, Jae-Young Chung
Development of a physiologically-based pharmacokinetic model for cyclosporine in Asian children with renal impairment. Translational and clinical pharmacology 27 (3) (2019)